Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-25 @ 9:18 PM
Study NCT ID:
NCT06032156
Status:
RECRUITING
Last Update Posted:
2023-12-07
First Post:
2023-04-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ketone Dose and Cerebral Blood Flow Study
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'BASIC_SCIENCE', 'interventionModel': 'CROSSOVER', 'interventionModelDescription': 'A randomized double-blind placebo-controlled crossover design will be used to test 3 conditions. Participants will consume 60 mL of a supplement containing: 1) a low β-OHB dose (0.3g/kg) body weight of the ketone monoester; \\[R\\]-3-hydroxybutyl \\[R\\]-3-hydroxybutyrate); 2) a high β-OHB dose (0.6g/kg body weight); or 3) a taste-matched calorie-free inert placebo drink.'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 20}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-11-08', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-12', 'completionDateStruct': {'date': '2024-08', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-12-01', 'studyFirstSubmitDate': '2023-04-06', 'studyFirstSubmitQcDate': '2023-09-08', 'lastUpdatePostDateStruct': {'date': '2023-12-07', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-09-11', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-05', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Resting cerebral blood flow (CBF)', 'timeFrame': '2-hour', 'description': 'Measured via duplex ultrasound of the extra-cranial arteries (internal carotid and vertebral arteries).'}], 'secondaryOutcomes': [{'measure': 'Cognitive Function', 'timeFrame': '2-hour', 'description': 'The MST (Mnemonic Similarity Task) will be used to assess hippocampal-dependent memory and pattern separation.'}, {'measure': 'Plasma beta-hydroxybutyrate area under the curve', 'timeFrame': '2-hour', 'description': 'Venous blood samples will be obtained via intravenous catheter'}, {'measure': 'Brain-derived neurotrophic factor (BDNF)', 'timeFrame': '2-hour, then following completion of submaximal exercise bout', 'description': 'Serum and plasma BDNF measured in venous blood samples will be obtained via intravenous catheter'}, {'measure': 'Oxygen uptake (VO2)', 'timeFrame': '2-hour, then during submaximal exercise (performed after 2-hour rest period)', 'description': 'Breath-by-breath analysis performed via metabolic cart'}, {'measure': 'End-tidal CO2', 'timeFrame': '2-hour, then during submaximal exercise (performed after 2-hour rest period)', 'description': 'Breath-by-breath analysis performed via PowerLab Gas Analyzer (AD Instruments)'}, {'measure': 'Mean arterial pressure (MAP)', 'timeFrame': '2-hour', 'description': 'Automated blood pressure cuff measurement of brachial artery pressure in mmHg.'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Cerebral Blood Flow', 'Cognition', 'Beta-hydroxybutyrate (β-OHB)'], 'conditions': ['Cerebrovascular Function', 'Cognition']}, 'descriptionModule': {'briefSummary': 'Ketone bodies are produced by the liver during periods of food scarcity or severe carbohydrate restriction. Blood ketones are an alternative fuel source used by the brain, heart, and skeletal muscle during periods of fasting. Further, ketones bodies act as a signalling molecule that have pleiotropic effects that upregulate cellular stress-resistance pathways throughout the body.\n\nOral supplements containing exogenous ketones have recently become available and represent a novel tool for increasing plasma ketone bodies without the need for dietary restriction. Early evidence suggests that oral ketone supplements may enhance cerebral blood flow and improve cognition. However, the dose-dependent effects of a single ketone supplement on cerebral blood flow and cognition in young adults is currently unknown.\n\nThe purpose of this study is to characterize the effects of ingesting a high versus low dose of an oral ketone monoester on cerebral blood flow, circulating blood markers, and cognition in young adults.\n\nAs an exploratory aim, this study will investigate how oxygen uptake kinetics during submaximal exercise are impacted 2 hours after ingestion of a ketone supplement. Recent findings indicate that ketone supplementation may impair exercise performance due to the physiological stress (i.e., pH disturbances) imposed by an acute ketone dose. Delaying exercise onset by 2 hours after ingestion of a ketone supplement may enhance oxygen kinetics in a dose-dependent manner.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '35 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n\\- Between the ages of 18 and 35\n\nExclusion Criteria:\n\n* Presence of obesity (body mass index \\> 30 kg/m\\^2)\n* Presence of known cardiovascular disease\n* Presence of type 2 diabetes\n* History of cardiovascular events requiring hospitalization (i.e., heart attack)\n* History of concussion(s) with persistent symptoms\n* Currently following a ketogenic diet and/or taking ketone body supplements'}, 'identificationModule': {'nctId': 'NCT06032156', 'acronym': 'kCBF', 'briefTitle': 'Ketone Dose and Cerebral Blood Flow Study', 'organization': {'class': 'OTHER', 'fullName': 'McMaster University'}, 'officialTitle': 'The Acute Effects of a High Versus Low Dose of a Ketone Monoester Supplement on Cerebral Blood Flow and Cognition', 'orgStudyIdInfo': {'id': 'kCBF'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'description': 'Single dose of a taste-matched calorie-free placebo', 'interventionNames': ['Other: Placebo']}, {'type': 'EXPERIMENTAL', 'label': 'High Dose β-OHB', 'description': 'Single dose of a ketone monoester (\\[R\\]-3-hydroxybutyl \\[R\\]-3-hydroxybutyrate; 0.6 g β-OHB/kg body weight)', 'interventionNames': ['Dietary Supplement: High Dose β-OHB']}, {'type': 'EXPERIMENTAL', 'label': 'Low Dose β-OHB', 'description': 'Single dose of a ketone monoester (\\[R\\]-3-hydroxybutyl \\[R\\]-3-hydroxybutyrate; 0.3 g β-OHB/kg body weight)', 'interventionNames': ['Dietary Supplement: Low Dose β-OHB']}], 'interventions': [{'name': 'Low Dose β-OHB', 'type': 'DIETARY_SUPPLEMENT', 'description': 'Ingestion of a low dose \\[R\\]-3-hydroxybutyl \\[R\\]-3-hydroxybutyrate (0.3 g β-OHB/kg body weight) followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.', 'armGroupLabels': ['Low Dose β-OHB']}, {'name': 'High Dose β-OHB', 'type': 'DIETARY_SUPPLEMENT', 'description': 'Ingestion of a high dose \\[R\\]-3-hydroxybutyl \\[R\\]-3-hydroxybutyrate (0.6 g β-OHB/kg body weight) followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.', 'armGroupLabels': ['High Dose β-OHB']}, {'name': 'Placebo', 'type': 'OTHER', 'description': 'Ingestion of a taste-matched calorie-free placebo drink followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.', 'armGroupLabels': ['Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': 'L8S 4K1', 'city': 'Hamilton', 'state': 'Ontario', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Jeremy Walsh, PhD', 'role': 'CONTACT', 'email': 'walshj18@mcmaster.ca', 'phone': '9055259140', 'phoneExt': '23523'}], 'facility': 'McMaster University', 'geoPoint': {'lat': 43.25011, 'lon': -79.84963}}], 'centralContacts': [{'name': 'Jeremy J Walsh, PhD', 'role': 'CONTACT', 'email': 'walshj18@mcmaster.ca', 'phone': '905-525-9140', 'phoneExt': '23523'}], 'overallOfficials': [{'name': 'Jeremy J Walsh, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'McMaster University'}]}, 'ipdSharingStatementModule': {'infoTypes': ['STUDY_PROTOCOL', 'SAP'], 'timeFrame': 'Beginning 12 months and ending 36 months following article publication.', 'ipdSharing': 'YES', 'description': 'The investigators will share individual patient data (de-identified) with researchers upon request', 'accessCriteria': 'Anyone who wishes to access the data.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'McMaster University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}